Institution
Istituto Oncologico della Svizzera Italiana
Also known as: Oncology Institute of Southern Switzerland · IOSI
- 25running trials
- 10closed trials
- 3,809publications (OpenAlex)
Running trials
Recruiting
Recruiting
Terbinafine for Biochemically Recurrent Prostate Cancer (TerbinaPro)
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Active, not recruiting
Recruiting
Lifestyle Intervention in Patients With Metastatic Prostate Cancer
Recruiting
Metronidazole as Preoperative Therapy in CRC / FusoMetro-001
Active, not recruiting
Recruiting
Recruiting
Recruiting
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Active, not recruiting
A Study of Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101)
Enrolling by invitation
Long-Term Follow-Up Study After Gene-Modified Cell Treatment in Kite Studies
Active, not recruiting
Recruiting
MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)
Active, not recruiting
Recruiting
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Active, not recruiting
Reduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma
Recruiting
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
Recruiting
Valid Biomarkers in Blood to Predict the Response to Therapy in Prostate Cancer Patients
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Prostate cancer6 recruiting
- Lung cancer3 recruiting
- Ovarian cancer3 recruiting
- Childhood cancers2 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Colorectal cancer1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Follicular lymphoma1 recruiting
- Mantle cell lymphoma1 recruiting
- Melanoma1 recruiting
- Sarcoma1 recruiting
Closed trials
Withdrawn
Completed
Terminated
Study of Brexucabtagene Autoleucel in Adults With Rare B-cell Malignancies
Completed
Terminated
Atezolizumab Plus 8 Gy Single-fraction Radiotherapy for Advanced Oligoprogressive NSCLC
Terminated
ODM-201 Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents.
Completed
Completed
Completed
Terminated
SwissNET - a Registry for Neuroendocrine Tumours in Switzerland
Registry name variants (9)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Istituto Oncologico della Svizzera Italiana
Bellinzona, 6500
13 trials
Oncology Institute of Southern Switzerland
Bellinzona, Canton Ticino 6500
7 trials
Istituto Oncologico della Svizzera Italiana (IOSI)
Bellinzona, 6500
6 trials
Oncology Institute of Southern Switzerland (IOSI)
Bellinzona, Canton Ticino 6500
4 trials
EOC - Istituto Oncologico della Svizzera Italiana
Bellinzona, 6500
2 trials
NCT07365423Terbinafine for Biochemically Recurrent Prostate Cancer (TerbinaPro)
Contact: Thomas Zilli, Prof
Contact: Thomas Zilli, Prof
Istituto Oncologico Della Svizzera Italiana (Iosi) Di Bellinzona
Bellinzona, 06500
1 trial
Istituto Oncologico Svizzera Italiana
Bellinzona, 6500
1 trial
Contact: Patrizia Froesch, MD (principal investigator)
Oncology Institute of Southern Switzerland (IOSI) - Department of Oncology
Bellinzona, 6500
1 trial
Oncology Institute of Southern Switzerland (IOSI)-Ente Ospedaliero Cantonale (EOC)
Bellinzona, Canton Ticino 6500
1 trial
NCT04111978MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)
Contact: Ilaria Colombo, Dr med
Conditions
Diseases this institution publishes on or runs trials for.
- Prostate cancer67 works · 8 trials
- Mantle cell lymphoma6 works · 1 trial
Institution data: ROR 04tty5b50 (CC0-1.0)Updated 15 Nov 2026